Advertisement

Co-morbidities

  • Pastora Gallego
Chapter
Part of the Congenital Heart Disease in Adolescents and Adults book series (CHDAA)

Abstract

Prevalence of heart failure is increasing in the ageing adult congenital heart disease (ACHD) population. Adult co-morbidities such as respiratory and liver diseases, renal dysfunction, anaemia, endocrine disorders, cognitive dysfunction, cardiovascular risk factors and acquired cardiovascular disease complicate heart failure (HF) care. These conditions further contribute to HF progression, may alter the response to treatment and are modifiers of outcomes. Optimal care of these patients, therefore, requires a careful and comprehensive multidisciplinary approach.

Keywords

Co-morbidities Renal dysfunction Respiratory disease Cardiovascular disease Liver disease Extra-cardiac complications 

References

  1. 1.
    Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, Buchhorn R. Incidence and risk distribution of heart failure in adolescent and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97:1238–43.CrossRefPubMedGoogle Scholar
  2. 2.
    Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric congenital heart disease: burden of disease and predictors of mortality. J Am Coll Cardiol. 2011;58:1509–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A, Dimopoulos K, Swan L, Gatzoulis M, Diller GP. Congenital heart disease beyond the age of 60: emergence of a new population with high resourcce utilization, high morbidity and high mortality. Eur Heart J. 2014;35:725–32.CrossRefPubMedGoogle Scholar
  5. 5.
    Billet J, Majeed A, Gatzoulis M, Cowie M. Trends in hospital admissions, in-hospital case fatality and population mortality from congenital heart disease in England, 1994 to 2004. Heart. 2008;94:342–8.CrossRefGoogle Scholar
  6. 6.
    Lui GK, Fernandes S, MacElhinney DB. Management of cardiovascular risk factors in adult with congenital heart disease. J Am Heart Assoc. 2014;3(6):e001076.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Cohen SB, Ginde S, Bartz PJ, Earing MG. Extracardiac complications in adults with congenital heart disease. Congenit Heart Dis. 2013;8:370–80.PubMedGoogle Scholar
  8. 8.
    Yalonetsky S, Horlick EM, Osten MD, Benson LN, Oechslin EN, Silversides CK. Clincal characteristics of coronary artery disease in adults with congenital heart defects. Int J Cardiol. 2013;164:217–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Fedchenko M, Mandalenakis Z, Rosengren A, Lappas G, Eriksson P, Skoglund K, Dellborg M. Ischemic heart disease in children and young adults with congenital heart disease in Sweden. Int J Cardiol. 2017;248:143–8.  https://doi.org/10.1016/j.ijcard.2017.06.120.CrossRefPubMedGoogle Scholar
  10. 10.
    Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease. Incidence, cumulative risk and predictors. Circulation. 2015;132:2385–94.CrossRefPubMedGoogle Scholar
  11. 11.
    Valente AM, Bhatt AB, Cook S, Earing MG, Gersony DR, Aboulhosn J, Opotowsky AR, Lui G, Gurvitz M, Graham D, Fernandes SM, Khairy P, Webb G, Gerhard-Herman M, Landzberg MJ, Investigators A. The CALF (congenital heart disease in adults lower extremities systemic venous health in Fontan patients) study. J Am Coll Cardiol. 2010;56:144–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Kuijpers JM, Mulder BJM. Aortopathies in adult congenital heart disease and genetic aortopathy syndromes: management strategies and indications for surgery. Heart. 2017;103(12):952–66.CrossRefPubMedGoogle Scholar
  13. 13.
    Martinez-Quintana E, Rodriguez-Gonzalez F, Nieto-Lago V, Novoa FJ, Lopez-Rios L, Riaño-Ruiz M. Serum glucose and lipid levels in adult congenital heart disease. Metabolism. 2010;59:1642–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Rosenthal TM, Leung ST, Ahmad R, Young T, Lavie CJ, Moodie DS, Shah S. Lifestyle modification for the prevention of morbidity and mortality in adult congenital heart disease. Congenit Heart Dis. 2016;11:1189–98.CrossRefGoogle Scholar
  15. 15.
    Dellborg M, Björk A, Pirouzi Fard MN, Ambring A, Eriksson P, Svensson AM, Gudbjörnsdottir S. High mortality and morbidityamong adults with congenital heart disease and type 2 diabetes. Scand Cardiovasc J. 2015;49:344–50.PubMedGoogle Scholar
  16. 16.
    Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med. 2013;159(5):ITC3-1–ITC3-15.CrossRefGoogle Scholar
  17. 17.
    Deen JF, Krieger EV, Slee AE, Arslan A, Arterburn D, Stout K, Portman MA. Metabolic syndrome in adults with congenital heart disease. J Am Heart Assoc. 2016;5:e001132.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, Babu-Narayan S, Wort SJ, Dimopoulus K, Gatzoulis M. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow up at a large tertiary Centre. Circulation. 2015;132(22):2118–25.CrossRefPubMedGoogle Scholar
  19. 19.
    Hjortshoj CS, Jensen AS, Christiensen JAE, Jennum P, Sondergaard L. Sleep-disordered breathing in Eisenmenger syndrome. Am J Cardiol. 2016;214:23–4.Google Scholar
  20. 20.
    Cotts T, Smith KR, Lu J, Dorfman AL, Norris MD. Risk for sleep-disordered breathing in adults after atrial switch repairs for d-looped transposition of the great arteries. Pediatr Cardiol. 2014;35:888–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Pillutla P, Shetty KD, Foster E. Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am J Cardiol. 2009;158:874–9.Google Scholar
  22. 22.
    Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wurstmann K, Charalambides M, Silva M, Swan L, Dimopoulos K, Gatzoulis M. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy and association with survival. Circulation. 2013;127:882–90.CrossRefPubMedGoogle Scholar
  23. 23.
    Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group. The prognosic importance of lung function in patients admitted with heart failure. Eur J Heart Fail. 2010;12:685–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Dimopoulos K, Diller GP, Petrarco R, Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis M, Giannakoulas G. Anaemia in adults with congenital heart disease relates to adverse outcomes. J Am Coll Cardiol. 2009;54:2093–100.CrossRefPubMedGoogle Scholar
  25. 25.
    Collins N, Piran S, Harrison J, Azevedo E, Oechslin E, Silversides C. Prevalence and determinants of anaemia in adults with congenital heart disease and ventricular dysfunction (subaortic right ventricle and single ventricle physiology). Am J Cardiol. 2008;102:625–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulos SA, Babu-Narayan S, Salukhe TV, Piepoli MF, Pool-Wilson PA, Best N, Francis DP, Gatzoulis M. Prevalence, predictors and prognostic value of renal dysfuncion in adults with congenital heart disease. Circulation. 2008;117:2320–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Marelli AJ, Miller SP, Marino BL, Jefferson AL, Newburger JW. Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation. 2016;133:1951–62.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Ilardi D, Ono KE, McCartney R, Book W, Stringer AY. Neurocongnitive functioning in adults with congenital heart disease. Congenit Heart Dis. 2017;12(2):166–73.CrossRefPubMedGoogle Scholar
  29. 29.
    Diller GP, Bräutingam A, Kempny A, Uebing A, Alonso-Gonzalez R, Swan L, Babu-Narayan SV, Baumgartner H, Dimopoulus K, Gatzoulis M. Depression requiring anti-depressant drug therapy in adult congenital heart disease: prevalence, risk factors and prgnostic value. Eur Heart J. 2016;37:771–82.CrossRefPubMedGoogle Scholar
  30. 30.
    Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, Ong L, Colman J, Oechslin E, Nolan RP. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137:158–64.CrossRefPubMedGoogle Scholar
  31. 31.
    Billet J, Cowie MR, Gatzoulis MA, Vonder Muhl JF, Majeed A. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysis. Heart. 2008;94:1194–9.CrossRefGoogle Scholar
  32. 32.
    Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology. 2012;56:1160–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med. 2007;46:1063–70.CrossRefPubMedGoogle Scholar
  34. 34.
    Shiina Y, Toyoda T, Kawasoe Y, Tateno S, Shirai T, Matsuo K, et al. The prevalence and risk factors for cholelitiasis and asymptomatic gallstones in adults with congenital heart disease. Int J Cardiol. 2011;152:171–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Bryant T, Ahmad Z, Millward-Sadler H, Burney K, Stedman B, Kendall T, et al. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac complications. Int J Cardiol. 2010;151:268–72.CrossRefPubMedGoogle Scholar
  36. 36.
    Floriani C, Gencer B, Collet TH, Rondoni N. Subclinical thyroid dysfunction and cardiovascular disease: 2016 update. Eur Heart J. 2018;39(7):503–7.  https://doi.org/10.1093/eurheartj/ehx050.CrossRefPubMedGoogle Scholar
  37. 37.
    Martínez-Quintana E, Rodriguez-Gonzalez F, Nieto-Lago V. Subclinical hypothyroidism in grown-up congenital heart disease patients. Pediatr Cardiol. 2013;34:912–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone associated thyroid dysfunction. Risk factors in adults with congenital heart disease. Circulation. 1999;100:149–54.CrossRefPubMedGoogle Scholar
  39. 39.
    Opotowsky AR, Moko LE, Ginns J, Rosenbaum M, Gretumann M, Aboulhosn J, Hageman A, Kim Y, Deng LX, Grewal J, Zaidi AN, Almanssori G, Oechsling E, Earing M, Landzberg M, Singh MN, Wu F, Vaidya A. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J Clin Endocrinol Metab. 2015;100(4):1325–34.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Ponz de Antonio I, Ruiz-Cantador J, Gonzalez AE, Oliver JM, Sanchez-Recalde A, Lopez-Sendon JL. Prevalence of neuroendocrine tumors in patients with cyanotic congenital heart disease. Rev Esp Cardiol. 2017;70(8):669–81.CrossRefGoogle Scholar
  41. 41.
    Mayer O, Campbell R, Cahill P, Redding G. Thoracic insufficiency syndrome. Curr Probl Pediatr Adolesc Health Care. 2016;46(3):72–97.CrossRefPubMedGoogle Scholar
  42. 42.
    Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol. 2009;54(5):460–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Vergeut G, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerd GT, Plokker HW, Grobbee DE, Mulder BJ. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96:872–8.CrossRefGoogle Scholar
  44. 44.
    Bracher I, Padrutt M, Bonassin F, Santos Lopes B, Gruner C, Stämpfli SF, Oxenious A, De Pasquuale G, Seliger T, Lüscher TF, Attenhoffer Jost C, Greutmann M. Burden and impact of congenital syndromes and comorbidities among adults with congenital heart disease. Int J Cardiol. 2017;240:159–64.CrossRefPubMedGoogle Scholar
  45. 45.
    Braunstein JB, Anderson G, Gerstenblith GF, Weller W, Niefeld M, Herbert R, Wu AW. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226–33.CrossRefPubMedGoogle Scholar
  46. 46.
    Dimopoulos K, Diller GP, Giannakoulas G, Petrarco R, Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF, Pool-Wilson PA, Francis DP, Gatzoulis M. Anaemia in adults with congenital heart disease relates to adverse outcomes. J Am Coll Cardiol. 2009;54(22):2093–100.CrossRefPubMedGoogle Scholar
  47. 47.
    Damman K, Valente AM, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455–69.CrossRefPubMedGoogle Scholar
  48. 48.
    Pankau R, Partsch CJ, Winter M, Gosch A, Wessel A. Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome. Am J Med Genet. 1996;63:301–4.CrossRefPubMedGoogle Scholar
  49. 49.
    Morgan C, Al-Alklabi M, Garcia Guerra G. Chronic kidney disease in congenital heart disease patients: a narrative review of evidence. Can J Kidney Health Dis. 2015;2:163–9.CrossRefGoogle Scholar
  50. 50.
    Buelow MW, Dall A, Bartz PJ, Tweddell JS, Sowinski J, Rudd N, Karzmark L, Earing MG. Renal dysfunction is common among adults after palliation for previous tetralogy of Fallot. Pediatr Cardiol. 2013;34(1):165–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Ohuchi H, Diller GP. Biomarkers in adult congenital heart disease heart failure. Heart Fail Clin. 2014;10:43–56.CrossRefPubMedGoogle Scholar
  52. 52.
    Chong VH, Singh J, Parry H, Saunders J, Chowdhury F, Mancini DM, Lang CC. Management of noncardiac comorbidities in chronic heart failure. Cardiovasc Ther. 2015;33:300–15.CrossRefPubMedGoogle Scholar
  53. 53.
    Aydin SI, Seiden HS, Blaufox AD, Parnell VA, Choudhury T, Punnose A, et al. Acute kidney injury after surgery for congenital heart disease. Ann Thorac Surg. 2012;945:1589–95.CrossRefGoogle Scholar
  54. 54.
    Lam CC, Mancini D. Noncardiac comorbidities in chronic heart failure. Heart. 2007;93:665–71.CrossRefGoogle Scholar
  55. 55.
    Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, et al. Blunted erythropoietin productivo and defective iron supply for erythropoiesis as major causses of anaemia in patients with chronic heart failure. Eur Heart J. 2005;26:2232–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anaemia of severe, resistant congestive heart failure improves cardiac and renal function and functional class and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737–44.CrossRefPubMedGoogle Scholar
  57. 57.
    Broberg CS, Jayaweera AR, Diller GP, Prasad SK, Lay Thein S, Bax BE, Burman J, Gatzoulis M. Seeking optimal relation between oxygen saturation and hemoglobine concentration in adults with cyanosis from congenital heart disease. Am J Cardiol. 2011;107(4):595–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Tay ELW, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis M. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or Eisenmenger syndrome. Int J Cardiol. 2011;151(3):307–12.CrossRefPubMedGoogle Scholar
  59. 59.
    Jensen AS, Idorn L, Thomsen C, Von der Recke P, Mortensen J, Sorensen KE, Thilen U, Nagy E, Kofoed KF, Ostrowski SR, Sondergaard L. Prevalence of cerebral and pulmonar thrombosis in patients with cyanotic congenital heart disease. Heart. 2015;101(19):1540–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Jensen AS, Johanson PI, Sorensen KE, Thilen U, Nagy E, Furenäs L, Sondergaard L. The haematocrit- an importan factor causing impaired haemostasis in patients with cyanotic congental heart disease. Int J Cardiol. 2013;167:1317–21.CrossRefPubMedGoogle Scholar
  61. 61.
    Rosove MH, Perloff JK, Hocking WG, Child JS, Cannnobbio MM, Skorton DJ. Chronic hypoxemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet. 1996;2:313–5.Google Scholar
  62. 62.
    Wolk R, Kara T, Somers VR. Sleep-disordered breathing and cardiovascular disease. Circulation. 2003;108:9–12.CrossRefPubMedGoogle Scholar
  63. 63.
    Young T, Palta J, Dempsey J, Skatrud j WS, Bardr S. The occurrence if sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.CrossRefGoogle Scholar
  64. 64.
    Cormican LJ, Williams A. Sleep-disordered breathing and its treatment in chronic heart failure. Heart. 2005;91:1264–70.CrossRefGoogle Scholar
  65. 65.
    Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–60.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Ginde S, Bartz PJ, Hill GD, Danduran MJ, Sowinski J, Biller J, et al. Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease. Congenit Heart Dis. 2013;8:246–54.CrossRefPubMedGoogle Scholar
  67. 67.
    Opotowsky AR. Abnormal spirometry in congenital heart disease. Where do we go from here? Circulation. 2013;127:865–7.CrossRefPubMedGoogle Scholar
  68. 68.
    Pianosi PT, Johnson JN, Turchetta A, Johnson BD. Pulmonary function and ventilatory limitation to exercise in congenital heart disease. Congenit Heart Dis. 2009;4:2–11.CrossRefPubMedGoogle Scholar
  69. 69.
    Hollman RR, Paul SK, Bethel MA, Mathews DR, Neal HA. 10-year follow up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.CrossRefGoogle Scholar
  70. 70.
    Ohuchi H, Miyamoto Y, Yamamoto M, Ishihara H, Takata H, Miyazaki A, Yamada O, Yagihara T. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J. 2009;158:30–9.CrossRefPubMedGoogle Scholar
  71. 71.
    Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13:612–6.CrossRefPubMedGoogle Scholar
  72. 72.
    Giannakoulas G, Dimpopulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vantankulu MA, Berdard E, Diller GP, Papaphylactou M, Francis DP, Di Mario C, Gatzoulis M. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445–50.CrossRefPubMedGoogle Scholar
  73. 73.
    Roifmann I, Therrien J, Ionescu-Itu r, Pilote L, Guo L, Kotowyckz MA, Martucci G, Marelli AJ. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126(1):16–21.CrossRefGoogle Scholar
  74. 74.
    Rodriguez FH, Moodie DS, Parekh DR, Franklin WJ, Morales DL, Zafar F, Adams GJ, Fiedman RA, Rossano JW. Outcomes of heart failure-related hospitalizations in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8:513–9.CrossRefPubMedGoogle Scholar
  75. 75.
    Stulak JM, Dearani JA, Bukhart HM, Ammash NM, Philips SD, Schaff HV. Coronary artery disease in adult congenital heart disease: outcome after coronary artery bypass grafting. Ann Thorac Surg. 2012;93:116–22.CrossRefPubMedGoogle Scholar
  76. 76.
    Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibito and beta-blocker therapy. Circulation. 2001;103:1746–51.CrossRefPubMedGoogle Scholar
  77. 77.
    Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation. 1989;80:840–5.CrossRefPubMedGoogle Scholar
  78. 78.
    Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ. Low cardiac indez is associated with incident dementia and Alzheimer disease: the Framingham Heart Study. Circulation. 2015;131:1333–9.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension. Curr Treat Options Cardiovasc Med. 2002;4:267–73.CrossRefPubMedGoogle Scholar
  80. 80.
    Wong VW-S, Chan HL-Y. Transient elastography. J Gastroenterol Hepatol. 2010;25:1726–31.CrossRefPubMedGoogle Scholar
  81. 81.
    Rychik J, Veldman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells R. The precarious state of the liver after a Fontan operation. Summary of a multidisiciplinary symposium. Pediatr Cardiol. 2012;33:1001–12.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Watson NF, Bushnell T, Jones TK, Stout K. A novel method for the evaluation and treatment of obstructive sleep apnea in four adults with complex congenital heart disease and Fontan repairs. Sleep Breath. 2009;13:421–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Intercenter Adult Congenital Heart Disease Unit, Cardiology DepartmentHospital Universitario Virgen del RocioSevilleSpain

Personalised recommendations